Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  teloxantrone hydrochoride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase II Study of DuP 937 Administered Once Every Three Weeks in Patients with Refractory Solid Tumors (Summary Last Modified 06/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: GUMC-25190, NCI-V91-0048
Phase II Study of DuP 937 in Patients with non-Small Cell Lung Cancer (Summary Last Modified 12/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND57, NCI-V91-0146, IND57
Phase II Study of DuP 937 in Patients with Metastatic Malignant Melanoma (Summary Last Modified 12/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND56, NCI-V91-0145, IND56
Phase II Study of DuP 937 in Patients with Metastatic Colorectal Cancer (Summary Last Modified 02/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND58, NCI-V91-0147, IND58
Phase I Chemotherapy with CI-937 Given Weekly for Three Weeks Every Five Weeks in Adults with Locally Advanced or Metastatic Solid Tumors (Summary Last Modified 01/89)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND44, NCI-V88-0564, IND44
Start Over